Insider Trading Alert - TWX, CMS And BCR Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 18, 2014, 129 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $49.70 to $268,110,200.60.

Highlighted Stocks Traded by Insiders:

Time Warner (TWX) - FREE Research Report

Cappuccio Paul T who is EVP and General Counsel at Time Warner sold 23,379 shares at $65.45 on Feb. 18, 2014. Following this transaction, the EVP and General Counsel owned 66,531 shares meaning that the stake was reduced by 26% with the 23,379-share transaction.

The shares most recently traded at $65.14, down $0.31, or 0.48% since the insider transaction. Historical insider transactions for Time Warner go as follows:

  • 12-Week # shares bought: 1,600
  • 24-Week # shares bought: 1,600
  • 24-Week # shares sold: 205,681

The average volume for Time Warner has been 5.1 million shares per day over the past 30 days. Time Warner has a market cap of $59.1 billion and is part of the services sector and media industry. Shares are down 6.34% year-to-date as of the close of trading on Tuesday.

Time Warner Inc. operates as a media and entertainment company in the United States and internationally. The company operates in three segments: Networks, Film and TV Entertainment, and Publishing. The Networks segment consists of Turner Broadcasting System, Inc. and Home Box Office, Inc. The stock currently has a dividend yield of 1.94%. The company has a P/E ratio of 17.3. Currently there are 14 analysts that rate Time Warner a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TWX - FREE

TheStreet Quant Ratings rates Time Warner as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, notable return on equity and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Time Warner Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

CMS Energy (CMS) - FREE Research Report

Barba Glenn P who is VP, Controller, CAO at CMS Energy sold 15,000 shares at $28.00 on Feb. 18, 2014. Following this transaction, the VP, Controller, CAO owned 42,527 shares meaning that the stake was reduced by 26.07% with the 15,000-share transaction.

The shares most recently traded at $28.50, up $0.50, or 1.75% since the insider transaction. Historical insider transactions for CMS Energy go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 12,000

The average volume for CMS Energy has been 2.5 million shares per day over the past 30 days. CMS Energy has a market cap of $7.6 billion and is part of the utilities sector and utilities industry. Shares are up 6.35% year-to-date as of the close of trading on Tuesday.

Electric utility and natural gas. Sub. Is CMS Generation Co., an operator of power generation facilities. The stock currently has a dividend yield of 3.79%. The company has a P/E ratio of 17.2. Currently there are 4 analysts that rate CMS Energy a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CMS - FREE

TheStreet Quant Ratings rates CMS Energy as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full CMS Energy Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

C.R. Bard (BCR) - FREE Research Report

Groetelaars John P who is Group Vice President at C.R. Bard sold 3,745 shares at $137.48 on Feb. 18, 2014. Following this transaction, the Group Vice President owned 23,534 shares meaning that the stake was reduced by 13.73% with the 3,745-share transaction.

Christian Patricia G who is VP -Quality, Reg & Med Affairs at C.R. Bard sold 493 shares at $137.47 on Feb. 18, 2014. Following this transaction, the VP -Quality, Reg & Med Affairs owned 14,789 shares meaning that the stake was reduced by 3.23% with the 493-share transaction.

The shares most recently traded at $139.55, up $2.08, or 1.49% since the insider transaction. Historical insider transactions for C.R. Bard go as follows:

  • 4-Week # shares sold: 10,728
  • 12-Week # shares sold: 42,587
  • 24-Week # shares sold: 53,884

The average volume for C.R. Bard has been 628,200 shares per day over the past 30 days. C.R. Bard has a market cap of $10.8 billion and is part of the health care sector and health services industry. Shares are up 3.92% year-to-date as of the close of trading on Tuesday.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The stock currently has a dividend yield of 0.6%. The company has a P/E ratio of 24.1. Currently there are 4 analysts that rate C.R. Bard a buy, 1 analyst rates it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BCR - FREE

TheStreet Quant Ratings rates C.R. Bard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, solid stock price performance and impressive record of earnings per share growth. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full C.R. Bard Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Asian Markets Decline in Morning Trading

Asian Markets Decline in Morning Trading

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call